"The EAC remains the most diverse and interactive antibody meeting”
Dario Neri Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich
SVP and Head Global Clinical Development, Chief Medical Officer
Merck, Sharp & Dohme (MSD)
M. Anthony Moody
Associate Professor, Department of Paediatrics, Division of Infectious Diseases
Duke University Medical Centre
Chief Scientific Officer, Chief Medical Officer Prima BioMed
Head of Immuno-Oncology
Head, Department of Immunotherapy
Oncolytic viral therapy and cancer vaccines
Immunotherapy for solid tumours
Immune checkpoint inhibitors
Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October
"The EAC, managed by a very professional team, is a unique meeting that brings the entire mAbs stakeholder together with excellent speakers and sufficient time for networking. "
Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre
“ Good science, wide industrial and academic representation, great organization! ”
Head of Biostructure and Biophysics
"Great meeting, top speaker, perfect location, accomodation and catering "
Oncologist, University Hospital Basel
“Great depth and variety with engaging open discussions across industry/academic and biotech ”
Biomarker Development Specialist
Cancer Research UK Cambridge Institute